ABBV - AbbVie Inc.
| Previous Close | 85.27 |
| Open | 85.43 |
| Bid | 83.46 x 800 |
| Ask | 83.46 x 800 |
| Day's Range | 82.76 - 85.48 |
| 52 Week Range | 62.66 - 91.99 |
| Volume | 12,822,548 |
| Avg. Volume | 7,736,467 |
| Market Cap | 123.541B |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | 38.37 |
| EPS (TTM) | 2.18 |
| Earnings Date | Feb 06, 2020 |
| Forward Dividend & Yield | 4.72 (5.54%) |
| Ex-Dividend Date | Jan 13, 2020 |
| 1y Target Est | 95.18 |
- Zacks
What Lies Ahead for Healthcare ETFs in Q4 Earnings?
With earnings surprise in the cards, the healthcare sector is expected to witness substantial earnings growth of 4.4% in the fourth quarter, suggesting some room for potential upside for healthcare ETFs.
- Business Wire
FORM 8.3 - ABBVIE PLC - AMENDMENT
- Business Wire
Form 8.3 - Abbvie Plc - Amendment
- Business Wire
Form 8.3 - Abbvie Plc
- GuruFocus.com
Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments
Many other members of Big Pharma spent more on dividends and stock buybacks, a strategy some view as shortsighted Continue reading...
- MarketWatch
The one value strategy that wasn’t a disaster now favors commodity sector over techs
There was one value strategy that wasn’t a disaster in 2019, and it now likes commodity producers over techs.
- Zacks
How Trading Your Own Retirement Can Fleece Your Financial Future - January 23, 2020
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.
- Zacks
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, AbbVie (ABBV) closed at $87.20, marking a -0.9% move from the previous day.
- Zacks
J&J's (JNJ) Q4 Earnings Surpass Estimates, Sales Fall Short
J&J (JNJ) comes up with mixed fourth-quarter 2019 results.
- Business Wire
FORM 8.3 - ABBVIE PLC
- Zacks
5 Big Drug/Biotech Stocks Set to Trump Q4 Earnings Estimates
Let us take a look at some drug/biotech stocks that are poised to beat on earnings in the fourth quarter.
- Zacks
Simple Secrets Anyone Can Use to Reach Early Retirement - January 22, 2020
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
- Zacks
Roche's (RHHBY) Lymphoma Drug Polivy Gets Approval in Europe
Roche (RHHBY) obtains approval for Polivy in Europe for the treatment of adult patients with R/R DLBCL.
- Business Wire
Form 8.3 - ABBVIE INC
- Zacks
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - January 20, 2020
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
- MarketWatch
Social Security’s not keeping up with inflation — here’s what that means for you
Last fall, the Social Security Administration—overseen by its chief trustee, Treasury Secretary Steven Mnuchin—said benefits for nearly 69 million Americans would increase 1.6% in 2020. The figure, tied to the inflation rate, meant that the average recipient would get $24 more each month, or about $1,503 annually. This figure comes from the Bureau of Labor Statistics (part of the Labor Department), which publishes what’s called the “Consumer Price Index for Urban Wage Earners and Clerical Workers” (CPI-W) on a monthly basis.
- Zacks
Retirees Should Know These 3 Facts About Required Minimum Distributions - January 17, 2020
Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.
- Zacks
Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates
Lilly (LLY) offers to buy Dermira for $1.1 billion. AstraZeneca (AZN) and AbbVie (ABBV) provide pipeline updates.
- GuruFocus.com
T. Rowe Price Equity Income Fund Invests in Utility Company CenterPoint Energy
Fund releases 4th-quarter portfolio Continue reading...
- Business Wire
Form 8.3 - ABBVIE INC - AMENDMENT
- Barrons.com
Democrats Called for Cuts to Drug Prices at the Debate. The Pharma Industry Says It’s Trying.
Pharmaceutical executives at the J.P. Morgan Healthcare conference say the industry can fixed pricing problems on its own.
